International Callers: 310.390.2340
- Promises on Facebook
- |
- Promises on Twitter
- |
- Events
- |
- News
- |
- Articles
- |
- Alumni
- |
- Brochures
An anxiety medication known as D-cycloserine may be able to help suppress cravings and the possibility of relapse in cocaine addicts. According to a new study by researchers at Yale University, the anti-anxiety medication combined with cognitive behavioral therapy in cocaine addicts has the potential to help addicts resist drug consumption when faced with drug-taking cues, even when outside of rehabilitation treatment.
Ribonucleic acid (RNA) molecules are known to play important roles in the translation of genetic information into proteins. Over the last ten years, researchers have started noticing a population of small RNAs—called microRNAs—that represent a new class of molecules.
New research published by the American Psychological Association shows that the brain’s innate interest in the new and different may help trump the power of addictive drugs. The authors said that in controlled experiments, this novelty drew cocaine-treated rats away from the place where they received cocaine, suggesting that novelty could help break the vicious cycle of treatment and relapse, especially for the many addicts with novelty-craving, risk-taking personalities. Drug-linked settings hold particular sway over recovering addicts, which may account in part for high rates of relapse.
New animal studies found that stress-evoked changes in circuits that regulate serotonin in certain parts of the brain can precipitate a low mood and relapse in cocaine seeking.
Subscribe To RSS